FOR THE TREATMENT OF CHRONIC HEPATITIS C IN PATIENTS WITH COMPENSATED LIVER DISEASE PREVIOUSLY UNTREATED WITH ALPHA INTERFERON OR WHO HAVE RELAPSED FOLLOWING ALPHA INTERFERON THERAPY IN COMBINATION WITH RIBAVIRIN CAPSULES :
THE RECOMMENDED DURATION OF TREATMENT FOR PATIENTS PREVIOUSLY UNTREATED WITH INTERFERON IS 24 TO 48 WEEKS. THE DURATION OF TREATMENT SHOULD BE INDIVIDUALIZED TO THE PATIENT DEPENDING ON BASELINE DISEASE CHARACTERISTICS, RESPONSE TO THERAPY, AND TOLERABILITY OF THE REGIMEN.
IN PATIENTS WHO RELAPSE FOLLOWING INTERFERON THERAPY, THE RECOMMENDED DURATION OF TREATMENT IS 24 WEEKS.
ADULTS FROM 75 KG & ABOVE : 3 MILLION IU 3 TIMES WEEKLY S.C.
CHILDREN FROM 25 TO 61 KG : 3 MILLION IU/MΒ² 3 TIMES WEEKLY S.C.